Search research articles
Contact Us
Filters
Showing results (31-40 of 48) with videos related to
Page
of 5
Sort By:
Prostate Cancer and Prostatic Diseases
|
December 10, 2003
Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model
R A Bok, E J Hansell, T P Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 1999
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
E D Kwon, B A Foster, A A Hurwitz, et al.
Cancer Research
|
April 29, 2000
E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse
W J Wechter, D D Leipold, E D Murray, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Expression of biologically active heterodimeric bovine follicle-stimulating hormone in milk of transgenic mice
N M Greenberg, J W Anderson, A J Hsueh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 1997
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
E D Kwon, A A Hurwitz, B A Foster, et al.
Cancer Research
|
May 16, 2000
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade
A A Hurwitz, B A Foster, E D Kwon, et al.
Urology
|
December 22, 1999
Early castration reduces prostatic carcinogenesis in transgenic mice
M H Eng, L G Charles, B D Ross, et al.
Biology of the Cell
|
November 9, 2000
Centrosome-centriole abnormalities are markers for abnormal cell divisions and cancer in the transgenic adenocarcinoma mouse prostate (TRAMP) model
H Schatten, A M Wiedemeier, M Taylor, et al.
Oncogene
|
November 21, 2007
Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis
P J Kaplan-Lefko, B W Sutherland, A I Evangelou, et al.
Oncogene
|
August 6, 1999
Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line
P M Ghosh, N Ghosh-Choudhury, M L Moyer, et al.
Page
of 5
Search research articles
Search
Showing results (31-40 of 48) with videos related to
Sort By:
Page
of 5
Prostate Cancer and Prostatic Diseases
|
December 10, 2003
Patterns of protease production during prostate cancer progression: proteomic evidence for cascades in a transgenic model
R A Bok, E J Hansell, T P Nguyen, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
December 28, 1999
Elimination of residual metastatic prostate cancer after surgery and adjunctive cytotoxic T lymphocyte-associated antigen 4 (CTLA-4) blockade immunotherapy
E D Kwon, B A Foster, A A Hurwitz, et al.
Cancer Research
|
April 29, 2000
E-7869 (R-flurbiprofen) inhibits progression of prostate cancer in the TRAMP mouse
W J Wechter, D D Leipold, E D Murray, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
October 1, 1991
Expression of biologically active heterodimeric bovine follicle-stimulating hormone in milk of transgenic mice
N M Greenberg, J W Anderson, A J Hsueh, et al.
Proceedings of the National Academy of Sciences of the United States of America
|
July 22, 1997
Manipulation of T cell costimulatory and inhibitory signals for immunotherapy of prostate cancer
E D Kwon, A A Hurwitz, B A Foster, et al.
Cancer Research
|
May 16, 2000
Combination immunotherapy of primary prostate cancer in a transgenic mouse model using CTLA-4 blockade
A A Hurwitz, B A Foster, E D Kwon, et al.
Urology
|
December 22, 1999
Early castration reduces prostatic carcinogenesis in transgenic mice
M H Eng, L G Charles, B D Ross, et al.
Biology of the Cell
|
November 9, 2000
Centrosome-centriole abnormalities are markers for abnormal cell divisions and cancer in the transgenic adenocarcinoma mouse prostate (TRAMP) model
H Schatten, A M Wiedemeier, M Taylor, et al.
Oncogene
|
November 21, 2007
Enforced epithelial expression of IGF-1 causes hyperplastic prostate growth while negative selection is requisite for spontaneous metastogenesis
P J Kaplan-Lefko, B W Sutherland, A I Evangelou, et al.
Oncogene
|
August 6, 1999
Role of RhoA activation in the growth and morphology of a murine prostate tumor cell line
P M Ghosh, N Ghosh-Choudhury, M L Moyer, et al.
Page
of 5